Global Acute Bacterial Skin & Skin Structure Infections Treatment Market (ABSSI) By Infection Type (Hospital-Acquired ABSSI and Community-Acquired ABSSI), By Drug Type (Oral and Parental Antibiotics), By Route of Administration (Oral, Parental, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: June 2024
- Report ID: 95316
- Number of Pages: 348
- Format:
-
-
-
- Paratek Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Melinta Therapeutics, Inc.
- AbbVie Inc. Company Profile
- Sandoz International GmbH
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sun Pharmaceutical Industries Limited
- Aceragen, Inc.
- Pfizer Inc Company Profile
- Allergen
- Cumberland Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- Accord Healthcare ltd. (a subsidiary of Intas Pharmaceuticals Ltd.)
- Cadila Healthcare Ltd.
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible